Since the debut of the Versa on April 16th, Fitbit has revealed that it has already shipped more than one million of its new smartwatches. Also, the company said that since the female health tracking feature became available to the public a few weeks ago, about 2.5 million people have used it.
In terms of technical specifications, the Iconic, the bigger sibling of the Versa, possesses an integrated GPS, whereas the Versa does not. But it more than makes up for that by having a significantly lower price tag and having a look that is more understated. Simply put, the Versa simply has a more attractive appearance than the Ionic because of its rounded edges, polished appearance, and more compact form factor. A piece of equipment that both men and women would be pleased to wear in equal measure.
It is very clear that the firm is in a winning position here. The company’s CEO, James Park, made a promise earlier this year that they would release a wristwatch with “mass appeal” in 2018, and they have kept that promise. Because it strikes the ideal balance between being a smartwatch and a fitness watch, Fitbit’s hardware is clearly superior to that of its competitors. It shouldn’t come as much of a surprise that so many Versa gadgets have been shipped since the debut in April. With the release of the Fitbit Versa, we are making good on our promise to provide a smartwatch that has true consumer appeal and exciting new capabilities. James Park, co-founder and CEO of Fitbit, says that the positive response to Versa shows that we are meeting this need and puts us in a good position to get a piece of the smartwatch market, which is growing quickly.
The level of engagement we’ve seen with our newly added female health tracking feature shows that our users value being able to get a more complete picture of their overall health and wellness in one place, something that other cycle tracking tools on the market can’t do.
The success of Fitbit’s recently introduced female health tracking feature is another piece of positive news for the company. More than 2.4 million people have begun utilizing it; more than 1.8 million users have contributed at least one period to the calendar; more than 500,000 users have added two or more retrospective periods; and nearly 700,000 users have registered one or more symptoms.
At midmorning on Monday, Fitbit’s share price had increased by around 1 percent, reaching $5.71. Investors breathed a sigh of relief upon hearing the news because sales of fitness trackers manufactured by Fitbit had been on a declining trend over the past few years. The company is in desperate need of a solution to its financial woes, and initial feedback suggests that clients enjoy using Versa.